Zita Peach

Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia.

Part of Fresenius SE & Co. KGaA, Fresenius Kabi Australia Pty Ltd. is a healthcare company based in Sydney, Australia that specializes in producing and marketing pharmaceuticals and medical devices for the therapy and care of critically and chronically ill patients worldwide. The Australian company's product portfolio includes lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company offers a range of products such as biosimilars, colloids, enteral nutrition, i.v. drugs, medical devices, and parenteral nutrition. The company is committed to finding the best solutions for patient needs and their philosophy of "caring for life" stands for their passion to care for people all around the world.

AirXpanders, Inc. engaged in the design, manufacture, sale and distribution of medical devices. It offers AeroForm Tissue Expander System, a needle-free, patient-controlled tissue expander used in patients undergoing two-stage breast reconstruction following mastectomy prior to the insertion of a breast implant. The company was founded by Daniel I. Jacobs, Barry Cheskin, and Teddy Shalon on March 17, 2005 and was headquartered in San Jose, CA.

Hudson Institute of Medical Research is a leading Australian translational medical research institute located at Monash Health Translation Precinct in Victoria. The institute focuses on conducting research in the field of medical science to improve the health and well-being of people.

Mt Buller & Mt Stirling Resort Management (RMB) operates as a resort. It offers activities such as skiing, snowboarding, snow shoe, snow play, snow camp, fat bikes, walking, horse riding, scenic helicopter, and motorcycling. The company is headquartered in Mt. Buller, Australia.

Bionic Vision Technologies Pty Ltd. specializes in restoring functional vision for the blind. The private company is based in Carlton, Australia. The Australian company's retinal prosthesis system delivers visual information to the brain to improve the patient's awareness of external objects and surroundings. The CEO of the company is Ashraf Attia.

Part of Fresenius SE & Co. KGaA, Fresenius Kabi Asia Pacific Ltd. is a Chinese healthcare company that was founded in 2001. The company is based in Hong Kong, Hong Kong and specializes in providing lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. Fresenius Kabi is committed to making essential medicines and technologies accessible to healthcare professionals who help patients.

Haemokinesis Ltd. engages in production and distribution of medical devices. It offers point of care & emergency medicine solutions, hospital and private laboratory solutions, blood donor center solutions, and healthcare professional COVID-19 testing solutions. The company was founded in 2011 and is headquartered in Hallam, Australia.

Nucleus Network Ltd. engages in the ownership and operation of a clinical research organization. It offers product development consultation services, including regulatory strategy, pre-clinical gap analysis, and preparation of clinical trial documentation as well as provides regulatory submission services for clinical trials and marketing authorization applications. The firm also provides education services such as GCP education, classroom courses, seminars, certification reviews, certification review packages, online courses, resources and standard operating procedures related education services. The company was founded by Garry Jennings in 2003 and is headquartered in Melbourne, Australia.

Integrated Clinical Oncology Network Pty Ltd. engages in the provision of cancer and hematological care services. It offers chemotherapy compunding, pharmacy management, remote radiation therapy planning, and medical physics services. The firm also offers patients the option of emerging treatment through clinical trials. The company was founded by Stuart Giles in 2012 and is headquartered in South Brisbane, Australia.